Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 04, 2013 08:00 ET | Source: ABIOMED, Inc.

Abiomed Announces Several Reimbursement Milestones

Four Commercial Insurers Institute Broad Impella Coverage Impella Economic Study Published in The Journal of Managed Care Medicine (JMCM) DANVERS, Mass., March 4, 2013 (GLOBE NEWSWIRE) --...
February 27, 2013 08:00 ET | Source: ABIOMED, Inc.

Abiomed to Present at Cowen and Company 33rd Annual Health Care Conference

DANVERS, Mass., Feb. 27, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Susan V. Lisa, Senior Director,...
February 20, 2013 16:00 ET | Source: ABIOMED, Inc.

Abiomed Receives Close-Out Letter From Food and Drug Administration

DANVERS, Mass., Feb. 20, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that on February 19, 2013, Abiomed...
February 07, 2013 08:00 ET | Source: ABIOMED, Inc.

Abiomed to Present at Leerink Swann Global Healthcare Conference 2013

DANVERS, Mass., Feb. 7, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman,...
February 06, 2013 07:00 ET | Source: ABIOMED, Inc.

Abiomed Announces Revenue of $38.3 Million, Up 19% and Record Impella Patient Usage, Up 26%

DANVERS, Mass., Feb. 6, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today reported third quarter fiscal 2013 revenue of $38.3...
January 17, 2013 08:00 ET | Source: ABIOMED, Inc.

Abiomed Third Quarter Fiscal 2013 Earnings and Conference Call Notification

DANVERS, Mass., Jan. 17, 2013 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD) announced today that on Wednesday, February 6, 2013, the Company will release financial results for the third quarter of...
December 06, 2012 18:59 ET | Source: ABIOMED, Inc.

FDA 515i Reclassification Panel Recommends Class III Status for Temporary Ventricular Support Devices in the Non-Roller Type Cardiopulmonary Bypass Blood Pumps Category

DANVERS, Mass., Dec. 6, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that the U.S. Food and Drug...
November 21, 2012 11:24 ET | Source: ABIOMED, Inc.

Abiomed to Present at 24th Annual Piper Jaffray Healthcare Conference

DANVERS, Mass., Nov. 21, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman,...
November 16, 2012 18:30 ET | Source: ABIOMED, Inc.

Abiomed Believes Class Action Lawsuit is Without Merit and Intends to Defend Vigorously

DANVERS, Mass., Nov. 16, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that a purported class action complaint...
November 13, 2012 08:02 ET | Source: ABIOMED, Inc.

Abiomed Announces Stock Repurchase Program

DANVERS, Mass., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Abiomed, Inc. (Nasdaq:ABMD), a leading provider of breakthrough heart support technologies, today announced that its Board of Directors has authorized...